Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Ampio Pharmaceuticals Stock Is Surging Today

TheMotleyFool

0 0

Here's Why Ampio Pharmaceuticals Stock Is Surging TodayPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Shares of Ampio Pharmaceuticals (NYSEMKT: AMPE) are on the rise after the company released a positive second-quarter earnings report this morning. News of progress with the company's experimental COVID-19 treatment, Ampion, pushed the stock 17.5% higher as of 1:06 p.m. on Thursday.

This clinical-stage drugmaker didn't have any product revenue to report, but progress with an experimental COVID-19 treatment encouraged investors to drive the stock higher. After losing $3.6 million during the second quarter, Ampio Pharmaceuticals finished June with $20.5 million in cash on its balance sheet.

Image source: Getty Images.

Source Fool.com

Like: 0

AMPE

Share